ArticleJournal of personalized medicine2026

Glucagon-like Peptide-1 Receptor Agonists Are Not Associated with Increased Risk of Acute Pancreatitis or Pancreatic Complications, Including Pancreatic Cancer, in Type 2 Diabetes: A Global Propensity-Matched Cohort Study.

Yan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.